Viemed Healthcare (NASDAQ:VMD) Upgraded at Wall Street Zen

Viemed Healthcare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Viemed Healthcare from “buy” to “strong-buy,” while the broader analyst consensus remains “hold,” with an average price target of $14.
  • Viemed reported quarterly EPS of $0.11, missing the $0.12 estimate; revenue of $80.67 million also came in slightly below forecasts.
  • VMD shares opened at $9.13, between their 52-week low of $6.18 and high of $12.61; institutional investors own about 74.2% of the stock.
  • MarketBeat previews the top five stocks to own by December 1st.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a note issued to investors on Saturday, Wall Street Zen reports.

Other analysts have also recently issued reports about the stock. Weiss Ratings cut shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, August 17th. Freedom Capital lowered Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 5th. Finally, Barrington Research assumed coverage on shares of Viemed Healthcare in a research note on Monday, August 24th. They issued an "outperform" rating and a $14.00 target price for the company. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $14.00.

Get Our Latest Research Report on VMD

Viemed Healthcare Price Performance

Shares of VMD stock opened at $9.13 on Friday. The stock has a market cap of $347.76 million, a PE ratio of 26.22, a PEG ratio of 2.28 and a beta of 1.05. The firm's 50 day moving average price is $9.26 and its two-hundred day moving average price is $9.59. Viemed Healthcare has a 52-week low of $6.18 and a 52-week high of $12.61. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The company had revenue of $80.67 million during the quarter, compared to analyst estimates of $80.78 million. As a group, analysts forecast that Viemed Healthcare will post 0.41 EPS for the current year.

Institutional Trading of Viemed Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Diversified Trust Co increased its stake in Viemed Healthcare by 34.3% in the 3rd quarter. Diversified Trust Co now owns 15,597 shares of the company's stock valued at $142,000 after buying an additional 3,980 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in shares of Viemed Healthcare by 119.8% during the third quarter. Russell Investments Group Ltd. now owns 55,011 shares of the company's stock valued at $503,000 after purchasing an additional 29,981 shares during the period. StoneX Group Inc. bought a new position in Viemed Healthcare in the 3rd quarter worth approximately $167,000. CenterBook Partners LP purchased a new stake in shares of Viemed Healthcare during the third quarter valued at $249,000. Finally, Covestor Ltd acquired a new stake in shares of Viemed Healthcare during the third quarter worth $28,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc NASDAQ: VMD is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company's offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Viemed Healthcare Right Now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines